• STING agonist-1: Optimizing B Cell Activation Assays in Immu

  2026-05-09

  STING agonist-1 enables robust activation of the STING pathway, directly empowering immunology and cancer researchers to model B cell-driven tertiary lymphoid structures. This high-purity, DMSO-soluble immunology research reagent from APExBIO offers reproducible performance and unique mechanistic clarity for both basic and translational workflows.

• Oteseconazole (VT-1161): Redefining Candida Research Strateg

  2026-05-08

  Explore how Oteseconazole (VT-1161) is reshaping antifungal translational research with its mechanistic selectivity, robust activity against fluconazole-resistant Candida, and low risk of drug-drug interactions. This thought-leadership article bridges detailed mechanistic insight with actionable guidance for experimentalists, offering evidence-driven recommendations and protocol parameters for integrating Oteseconazole into advanced antifungal research workflows.

• Optimizing Tumor Imaging and Assays with Cy5.5 NHS Ester (A8

  2026-05-08

  This article provides a scenario-driven, evidence-based guide for biomedical researchers using Cy5.5 NHS ester (non-sulfonated) (SKU A8103). Through practical lab challenges, it demonstrates how this near-infrared fluorescent dye delivers reproducibility and sensitivity for protein conjugation, in vivo fluorescence imaging, and tumor microbiome research, supported by quantitative data and recent literature.

• hiPSC-Derived Intestinal Organoids for Pharmacokinetic Model

  2026-05-07

  This study presents a streamlined 3D protocol for generating human induced pluripotent stem cell (hiPSC)-derived intestinal organoids, offering a robust in vitro model for pharmacokinetic research. The findings address limitations of traditional models and enable more accurate assessment of intestinal drug metabolism relevant to human physiology.

• Reliable Apoptosis Research with Annexin V-Cy5/DAPI Apoptosi

  2026-05-07

  This authoritative guide addresses real-world laboratory challenges in programmed cell death detection by leveraging the Annexin V-Cy5/DAPI Apoptosis Kit (SKU K2255). It explores workflow optimization, data reproducibility, and vendor reliability, providing scenario-driven insights for biomedical researchers and lab technicians.

• Staurosporine: Broad-Spectrum Kinase Inhibitor for Cancer Re

  2026-05-06

  Staurosporine is a potent, broad-spectrum serine/threonine protein kinase inhibitor used extensively in cancer research. It enables precise modulation of kinase pathways and reliable induction of apoptosis in cancer cell lines. APExBIO’s Staurosporine (A8192) is validated for reproducibility and versatility in both mechanistic and translational studies.

• Merbromin Selectively Inhibits SARS-CoV-2 3CLpro: Insights a

  2026-05-06

  This study identifies Merbromin as a potent, mixed-type inhibitor highly selective for the SARS-CoV-2 main protease, 3CLpro, without significant inhibition of broad-spectrum serine proteases such as Proteinase K. The findings highlight both methodological advances in high-throughput screening and important considerations for inhibitor specificity in antiviral drug discovery.

• Tunicamycin: N-Glycosylation Inhibitor for ER Stress Researc

  2026-05-05

  Tunicamycin from APExBIO is a gold-standard N-glycosylation inhibitor for precisely inducing ER stress and dissecting inflammation pathways in macrophages and hepatocytes. This guide details advanced workflows, troubleshooting tips, and the translational impact of recent ER stress research, making it essential for labs targeting glycosylation and UPR signaling.

• Gastrin I Unlocks Human Gastric Acid Secretion Pathway Resea

  2026-05-05

  Human Gastrin I peptide is pivotal for precise modeling of gastric acid secretion and CCK2 receptor signaling in advanced organoid and stem cell-derived systems. This guide details stepwise protocols, key innovations from recent organoid studies, and actionable troubleshooting to maximize experimental fidelity for gastrointestinal research.

• Lipidated Nanophotosensitizers Disable Tumor EVs to Suppress

  2026-05-04

  This study introduces a lipidated nanophotosensitizer that enables both tracing and functional disabling of tumor extracellular vesicles (TEVs), thereby disrupting intercellular communication essential for metastasis. The findings establish a dual-action, light-activated strategy to inhibit both primary tumor growth and metastatic spread, offering new translational directions for exocytic pathway research.

• Telomere Recapping Restores Nuclear-Mitochondrial Balance in

  2026-05-04

  This study demonstrates that targeted telomere recapping using a catalytically inactive, nuclear-localized telomerase variant can block maladaptive telomere-to-mitochondrial DNA signaling in heart failure models. The findings provide compelling evidence for telomere-targeted gene therapy as a strategy to restore mitochondrial function and cardiac performance in diseased myocardium.

• Resiniferatoxin (RTX): Mechanistic Insights and Translationa

  2026-05-03

  Explore the unique mechanism and translational value of Resiniferatoxin (RTX), a highly selective TRPV1 agonist. This article provides in-depth scientific insight and practical guidance for leveraging RTX in advanced pain and inflammation research.

• Oteseconazole (VT-1161): Precision Antifungal Assays for Can

  2026-05-02

  Oteseconazole (VT-1161) stands out for its powerful, selective inhibition of fungal CYP51, enabling high-fidelity models of Candida infection and resistance. Its robust selectivity profile and streamlined assay compatibility make it indispensable for researchers tackling fluconazole-resistant Candida and recurrent vulvovaginal candidiasis.

• Azilsartan Medoxomil Monopotassium: Deep-Dive into AT1 Antag

  2026-05-01

  Explore the advanced pharmacology and assay optimization strategies for Azilsartan medoxomil monopotassium, a selective AT1 receptor antagonist. This article provides unique, evidence-based guidance for translational hypertension research, distinguishing itself through in-depth protocol analysis and practical application insights.

• RWJ 67657: Precision Targeting of p38α/β in Translational In

  2026-05-01

  This thought-leadership article explores the mechanistic and translational significance of RWJ 67657 (JNJ-3026582), a selective orally active inhibitor of p38α and p38β MAP kinases. It examines novel evidence for dual-action inhibition, contextualizes RWJ 67657 within the competitive kinase inhibitor landscape, and provides strategic guidance for researchers aiming to translate bench discoveries into preclinical models of inflammatory disease. The discussion is anchored by recent advances in understanding kinase dephosphorylation dynamics and positions RWJ 67657 as a next-generation tool for precision cytokine modulation, with practical insights for workflow design.

14708 records 1/981 page Next 12345 下5页 Last page